Therapeutic effect and mechanism of Xiaoyao Kangai Jieyu Recipe on mice with breast cancer related depression through regulating COX pathway.
10.19540/j.cnki.cjcmm.20230224.408
- Author:
Ying HE
1
;
Man-Shu ZOU
2
;
Ting-Ting REN
1
;
Ping LI
1
;
Yang LIU
1
;
Yuan-Shan HAN
3
Author Information
1. Science and Technology Innovation Center, Hunan University of Chinese Medicine Changsha 410208, China.
2. Science and Technology Innovation Center, Hunan University of Chinese Medicine Changsha 410208, China Hunan Provincial Key Laboratory of Traditional Chinese Medicine Prevention and Treatment of Depression Changsha 410208, China.
3. the First Hospital of Hunan University of Chinese Medicine Changsha 410007, China Hunan Provincial Key Laboratory of Traditional Chinese Medicine Prevention and Treatment of Depression Changsha 410208, China.
- Publication Type:Journal Article
- Keywords:
COX signaling pathway;
Xiaoyao Kangai Jieyu Recipe;
breast cancer related depression;
hippocampal neurons;
microglia
- MeSH:
Mice;
Animals;
Depression/genetics*;
Interleukin-18;
Cyclooxygenase 2/genetics*;
Hippocampus;
Glucose;
Neoplasms
- From:
China Journal of Chinese Materia Medica
2023;48(14):3874-3881
- CountryChina
- Language:Chinese
-
Abstract:
This study aimed to investigate the intervention effect and mechanism of Xiaoyao Kangai Jieyu Recipe(XKJR) on hip-pocampal microglia and neuronal damage in mice with breast cancer related depression. The mouse model of breast cancer related depression was established by inoculation of 4T1 breast cancer cells in axilla and subcutaneous injection of corticosterone(30 mg·kg~(-1)). The successfully modeled mice were randomly divided into a model group, a positive drug group(capecitabine 60 mg·kg~(-1)+fluoxetine 19.5 mg·kg~(-1)), and XKJR group(19.5 mg·kg~(-1) crude drug), with 6 in each group. Another 6 normal mice were taken as a normal group. The administration groups were given corresponding drugs by gavage, while the normal and model groups were given an equal volume of distilled water, once a day for 21 consecutive days. The depressive behavior of mice was assessed by glucose consumption test, open field test and novelty-suppressed feeding test. Hematoxylin and eosin(HE) staining and tumor suppression rate were used to evaluate the changes of axillary tumors. The mRNA expressions and the relative protein expressions of interleukin-1β(IL-1β), interleukin-18(IL-18), cyclooxyganese-2(COX-2) and glutamyl-prolyl-tRNA synthetase(EPRs) in the hippocampus of mice were determined by quantitative real-time polymerase chain reaction(qRT-PCR) and immunohistochemistry, respectively. Immunofluorescence was performed to detect the mean fluorescence intensity of CD11b, a marker of hippocampal microglia activation. Nissler staining and transmission electron microscopy were employed to observe the morphological changes and the ultramorphological changes of hippocampal neurons, respectively. The experimental results indicated that compared with the normal group, the model group had reduced glucose consumption and lowered number of total activities in open field test(P<0.05, P<0.01), prolonged first feeding latency in no-velty-suppressed feeding test(P<0.01), and significant depression-like behavior; the contents of IL-1β, IL-18, COX-2, and EPRs in hippocampus were increased(P<0.05, P<0.01), with hippocampal microglia activation and obvious neuronal damage. Compared with the model group, the positive drug group and the XKJR group presented an improvement in depressive behaviors, a decrease in the contents of IL-1β, IL-18, COX-2 and EPRs in hippocampus, and an alleviation in the activation of hippocampal microglia and neuronal damage; the tumor suppression rates of positive drug and XKJR were 40.32% and 48.83%, respectively, suggesting a lower tumor growth rate than that of the model group. In summary, XKJR may improve hippocampal microglia activation and neuronal damage in mice with breast cancer related depression through activating COX signaling pathway.
